cbdMD (YCBD)

Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On March 11, 2022, cbdMD, Inc. held its 2022 annual meeting of shareholders where four proposals were voted upon. The proposals are described in detail in our definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on January 27, 2022. Of the 58,546,720 shares of our common stock outstanding and entitled to vote at the annual meeting, 25,274,348 shares (or 43%), constituting a quorum, were represented in person or by proxy at the 2022 annual meeting. At the meeting all the proposals were approved and the final vote on the proposals was recorded as follows:

Proposal 1:The following directors were elected at the 2022 annual meeting of shareholders to hold office until the 2023 annual meeting of shareholders or their earlier resignation, removal or death:

Directors“For”“Against”Broker Non-Votes
Martin A. Sumichrast24,182,031584,982507,335
R. Scott Coffman24,570,174196,839507,335
Bakari Sellers18,735,4896,031,524507,335
William F. Raines, III24,361,892405,121507,335
Peter J. Ghiloni21,518,3543,248,659507,335
Scott G. Stephen24,714,09552,918507,335

Proposal 2:The appointment of Cherry Bekaert LLP as our independent registered public accounting firm was ratified, based upon the following final tabulation of votes: